X4 Pharmaceuticals (XFOR) Preferred Shares Issued (2017)

X4 Pharmaceuticals (XFOR) reported Preferred Shares Issued of $5.0 million for Q3 2017, up 1876.28% quarter-over-quarter from $253000.0 in Q2 2017.

X4 Pharmaceuticals (XFOR) Preferred Shares Issued (2017) Analysis & Trends

X4 Pharmaceuticals has reported Preferred Shares Issued for 1 years, with the latest figure at $5.0 million in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	X4 Pharmaceuticals	166.63 Mn	166.63 Mn	2.20 Mn	-

Download Data